Back
Viking Therapeutics, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
45
VKTX
Viking Therapeutics, Inc.
Last Price:
$38.53
Seasonality Move:
78.5%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiViking Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 78.4% based on the past 10 years of stock performance.
-
Viking Therapeutics, Inc. has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Viking Therapeutics, Inc. Stock Undervalued?The current Viking Therapeutics, Inc. [VKTX] share price is $35.41. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viking Therapeutics, Inc. has on average historically risen by 78.4% based on the past 10 years of stock performance.
Viking Therapeutics, Inc. Stock Rating
Sell
45
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. overpriced?
-
Viking Therapeutics, Inc. has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Viking Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
52.58
52-Week Low:
18.92
Prediction Charts
Market Cap:
4B
Price in USD:
35.41
Volume:
2.8M
Beta:
1.33
Technical Analysis
SMA50:
34.08
SMA100:
32.19
SMA200:
29.74
52-Wk Change:
-29.55%
Stock Predictions
-
Is Viking Therapeutics, Inc. stock public?Yes, Viking Therapeutics, Inc. is a publicly traded company.
-
What is the Viking Therapeutics, Inc. stock quote today?The Viking Therapeutics, Inc. stock price is 35.41 USD today.
-
How to buy Viking Therapeutics, Inc. stock online?You can buy Viking Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 40.39 | 39.00 | 40.88 | 38.40 |
| Nov-14 | 37.26 | 39.11 | 40.30 | 37.24 |
| Nov-17 | 38.07 | 38.22 | 38.75 | 36.86 |
| Nov-18 | 37.13 | 37.76 | 38.34 | 36.66 |
| Nov-19 | 38.05 | 36.04 | 38.12 | 35.39 |
| Nov-20 | 37.02 | 34.27 | 37.37 | 34.19 |
| Nov-21 | 34.03 | 34.26 | 34.93 | 32.90 |
| Nov-24 | 34.30 | 34.65 | 34.86 | 33.35 |
| Nov-25 | 34.54 | 35.46 | 35.51 | 33.44 |
| Nov-26 | 35.65 | 36.27 | 36.58 | 35.42 |
| Nov-28 | 36.45 | 36.81 | 36.83 | 36.08 |
| Dec-1 | 36.27 | 34.55 | 36.27 | 34.44 |
| Dec-2 | 34.64 | 33.88 | 35.42 | 33.85 |
| Dec-3 | 34.10 | 35.41 | 35.85 | 33.81 |
Viking Therapeutics, Inc. Earnings
Viking Therapeutics, Inc. Earnings Report: Per Share Viking Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics, Inc. Forecast Revenue Growth
Viking Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.